Evaluation of the effectiveness of complementary therapy with Portulaca oleracea capsule on the clinical symptoms of outpatients with COVID-19

Phase 3

• Conditions: U07.1; COVID-19; COVID-19.

• Registration Number: IRCT20190303042889N1
• Lead Sponsor: Mashhad University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 April 2021

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

Outpatient with COVID-19
Age 18-60 years
Patient satisfaction
Being alert and lacking organ damage
Confirmation of RT-PCR test for SARS-CoV-2
Blood saturated oxygen content more than 90%

Exclusion Criteria

Pregnant and lactating women
comorbidity
End stage Patient

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Improvement time of clinical manifestation based on questionnaire. Timepoint: The beginning of the intervention & day 14. Method of measurement: questionnaire.;Normalization of CRP and lymphopenia. Timepoint: The beginning of the intervention & day 14. Method of measurement: laboratory.